Featured Top Story
The price would make the two-dose vaccine more expensive for cash-paying customers than annual flu shots.
From
To
Health and Human Services Secretary Alex Azar says drugmakers will soon have to reveal the prices of their prescription medicines in their TV ads.
The Wall Street Journal says OxyContin maker Purdue Pharma is preparing a possible bankruptcy filing.
Dozens of drugmakers will start disclosing the prices for U.S. prescription drugs advertised on TV.
Two drugmakers are asking the Nevada Supreme Court to let a state court judge hear arguments before justices hear an appeal about whether the state can use their products for an execution.
Hackers have caused widespread disruption across Europe, hitting Ukraine especially hard. The second-largest drugmaker in the United States is also confirming it's been affected by the cyberattack.
Economics
Nevada state senators have passed a proposal aiming to force pharmaceutical companies to disclose how they set insulin prices. Bill 265 would impose some of the toughest regulations on pharmaceutical companies in the nation.
Commerce
Nevada lawmakers are doubling down on a push for information on why drugmakers are dramatically increasing prescription drug prices.
Pharmacology
Nevadans dismayed by soaring drug prices are asking state lawmakers to take unprecedented action intended to curb costs.
Mylan is releasing a generic version of its emergency allergy treatment EpiPen at half the price of the branded option, the cost of which drew scorn from parents nationwide and spawned Congressional inquiries.